Ahn Sun-Young, Mendoza Stanley, Kaplan George, Reznik Vivian
Department of Pediatrics, University of California San Diego, La Jolla, CA, 92093, USA.
Pediatr Nephrol. 2009 May;24(5):1047-53. doi: 10.1007/s00467-008-1101-x. Epub 2009 Jan 27.
Approximately 60% of VACTERL (vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula with atresia, renal defects/radial limb dysplasia) patients have renal anomalies that can be associated with chronic kidney disease (CKD). With improved medical care, a large proportion of these patients survive into adulthood. Longitudinal follow-up data regarding the management of kidney disease in these children is lacking. Twelve VACTERL patients with CKD stage 2-5 and 12 age-matched controls with similar urologic anomalies and CKD [mean follow-up period 15.0 +/- 1.4 (SE) and 11.9 +/- 2.1 years, respectively] were identified in a single center. Eight VACTERL patients progressed to end-stage renal disease (ESRD) compared to four controls (66.7 vs. 33.3%, respectively). Six VACTERL patients were dialyzed pre-transplant. Of the four patients on peritoneal dialysis (PD), three had to be switched to hemodialysis due to complications, whereas two of the three controls on PD did not experience significant problems. Seven VACTERL patients underwent renal transplantation compared to four controls. Mean creatinine clearance 2 years post-transplant was 65.8 +/- 6.3 in VACTERL patients vs. 87.8 +/- 7.1 ml/min per 1.73 m(2) in controls (p = 0.03). VACTERL patients had a significantly lower mean height standard deviation score than the controls (-2.34 +/- 0.41 vs. -1.27 +/- 0.24, respectively; p < 0.05). Based on these results, VACTERL patients with CKD develop ESRD more frequently, experience more complications with dialysis, may have a poorer transplant outcome, and have more severe growth failure than controls.
约60%的VACTERL(脊柱裂、肛门闭锁、心脏缺陷、食管闭锁合并气管食管瘘、肾脏缺陷/桡骨肢体发育不良)患者存在可能与慢性肾脏病(CKD)相关的肾脏异常。随着医疗护理的改善,这些患者中的很大一部分存活至成年。目前缺乏关于这些儿童肾脏疾病管理的纵向随访数据。在一个中心识别出12例CKD 2 - 5期的VACTERL患者以及12例年龄匹配、有相似泌尿系统异常和CKD的对照者[平均随访期分别为15.0±1.4(标准误)年和11.9±2.1年]。与4例对照者(分别为66.7%和33.3%)相比,8例VACTERL患者进展至终末期肾病(ESRD)。6例VACTERL患者在移植前接受透析。在接受腹膜透析(PD)的4例患者中,3例因并发症不得不转为血液透析,而在接受PD的3例对照者中,2例未出现重大问题。与4例对照者相比,7例VACTERL患者接受了肾移植。移植后2年,VACTERL患者的平均肌酐清除率为65.8±6.3,而对照者为87.8±7.1 ml/min/1.73 m²(p = 0.03)。VACTERL患者的平均身高标准差评分显著低于对照者(分别为 - 2.34±0.41和 - 1.27±0.24;p < 0.05)。基于这些结果,患有CKD的VACTERL患者比对照者更频繁地进展至ESRD,透析时出现更多并发症,移植结局可能更差,且生长发育障碍更严重。